📰 Prosight Management News
Page 2 - Prosight Management News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prosight Management. Real-time updates on events, politics, business and more.
September 8, 2023
Prosight Management LP purchased a new stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 25,210 shares of the company’s stock, valued at approximately $3,908,000. Johnson & Johnson accounts for approximately 1.9% of Prosight […]
September 8, 2023
Prosight Management LP acquired a new position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 25,210 shares of the company’s stock, valued at approximately $3,908,000. Johnson & Johnson comprises 1.9% of Prosight Management […]
September 7, 2023
Prosight Management LP reduced its stake in shares of Morphic Holding, Inc. (NASDAQ:MORF – Free Report) by 80.3% during the first quarter, Holdings Channel reports. The institutional investor owned 8,464 shares of the company’s stock after selling 34,485 shares during the period. Prosight Management LP’s holdings in Morphic were worth $319,000 as of its most […]
September 7, 2023
Prosight Management LP lifted its stake in shares of Humana Inc. (NYSE:HUM – Free Report) by 39.1% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 24,000 shares of the insurance provider’s stock after purchasing an additional 6,747 shares during the quarter. Humana […]
September 7, 2023
Prosight Management LP decreased its holdings in Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Free Report) by 55.3% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 383,447 shares of the biotechnology company’s stock after selling 475,262 shares during the quarter. Aldeyra Therapeutics makes up about […]
September 7, 2023
Prosight Management LP boosted its position in shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) by 133.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 753,528 shares of the company’s stock after acquiring an additional 430,774 shares during the quarter. AbCellera […]
September 7, 2023
Prosight Management LP lessened its holdings in Cue Biopharma, Inc. (NASDAQ:CUE – Free Report) by 37.4% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,151,855 shares of the company’s stock after selling 688,655 shares during the quarter. Cue Biopharma comprises 1.9% of Prosight Management […]
September 7, 2023
Prosight Management LP bought a new position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The firm bought 80,000 shares of the company’s stock, valued at approximately $8,098,000. Neurocrine Biosciences accounts for approximately 3.8% of Prosight Management LP’s investment […]
September 7, 2023
Prosight Management LP purchased a new position in Teladoc Health, Inc. (NYSE:TDOC – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 45,900 shares of the health services provider’s stock, valued at approximately $1,189,000. Other institutional investors and hedge […]
September 7, 2023
Prosight Management LP reduced its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 96.9% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 9,000 shares of the company’s stock after selling 280,335 shares during the period. Prosight Management LP’s holdings in LifeStance […]